DNA Chip Research Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
226,135.00
790,908.00
498,968.00
355,213.00
220,436.00
658,009
Total Accounts Receivable
119,274.00
87,746.00
90,876.00
112,549.00
128,806.00
134,620
Inventories
20,649.00
4,930.00
2,910.00
1,512.00
6,324.00
11,689
Other Current Assets
7,543.00
9,120.00
17,890.00
8,259.00
9,257.00
6,038
Total Current Assets
373,601.00
892,704.00
610,644.00
477,536.00
364,827.00
810,360
Net Property, Plant & Equipment
18,726.00
1,456.00
47,460.00
-
24,748.00
14,933
Total Investments and Advances
-
-
22,017.00
3,576.00
3,548.00
-
Intangible Assets
1,484.00
2,500.00
1,500.00
771.00
674.00
35,878
Other Assets
207.00
206.00
-
1,197.00
622.00
3,568
Total Assets
394,018.00
896,866.00
681,621.00
483,081.00
394,421.00
864,740
Accounts Payable
21,866.00
35,101.00
19,729.00
22,365.00
52,322.00
Income Tax Payable
3,541.00
4,289.00
6,257.00
7,813.00
8,225.00
Other Current Liabilities
27,574.00
20,972.00
21,494.00
29,629.00
32,507.00
Total Current Liabilities
52,981.00
60,362.00
47,480.00
59,807.00
93,054.00
Provision for Risks & Charges
2,300.00
3,111.00
3,813.00
4,881.00
6,196.00
Total Liabilities
55,281.00
63,473.00
51,293.00
64,688.00
99,250.00
Common Equity (Total)
338,737.00
833,393.00
630,328.00
418,392.00
295,171.00
Total Shareholders' Equity
338,737.00
833,393.00
630,328.00
418,392.00
295,171.00
Total Equity
338,737.00
833,393.00
630,328.00
418,392.00
295,171.00
Liabilities & Shareholders' Equity
394,018.00
896,866.00
681,621.00
483,080.00
394,421.00

About DNA Chip Research

View Profile
Address
Suzue Baydium, 5/F
Tokyo Tokyo 105
Japan
Employees -
Website http://www.dna-chip.co.jp
Updated 07/08/2019
DNA Chip Research, Inc. engages in the contract analysis and Deoxyribonucleic Acid (DNA) chip technology development. It operates through the Contract Research and Product Sales segments. The Contract Research segment offers contract analytical services, genomic medicine analysis services, diagnostic support services, and research development.